Table 1 (abstract P46). Rates of AEs
| Â | TCZ 12 mg/kg IV every 2 weeks | ||
|---|---|---|---|
| Â | Main Evaluation Period n = 11 | Optional Extension Period n = 7 | Entire Study Period n = 11 |
Total patient-years at risk | 2.3 | 5.1 | 7.4 |
Number of events (AE rate per 100 patient-years at risk) | |||
 Any AE | 32 (1396.4) | 47 (926.5) | 79 (1072.7) |
 Serious AE | 5 (218.2) | 2 (39.4) | 7 (95.1) |
 AE with fatal outcome | 0 | 0 | 0 |
 AE leading to withdrawal | 4 (174.6) | 1 (19.7) | 5 (67.9) |
 AE leading to dose interruption | 1 (43.6) | 12 (236.5) | 13 (176.5) |